Lena Sophie Tittel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lena Sophie Tittel has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kaushik Viswanathan Iyer
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, 55128, Germany
4 shared publications - Marie-Luise Winz
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany
4 shared publications - Max Müller
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany
3 shared publications - Alina-Andrea Kraft
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, 55128, Germany
1 shared publication - Chloé Astrid Walter
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, 55128, Germany
1 shared publication - Elisabeth Petfalski
University of Edinburgh
1 shared publication
Latest Publications
- Open Access
Jlp2 is an RQC complex-independent release factor acting on aberrant peptidyl-tRNA, protecting cells against translation elongation stress
Summary: Ribosome stalling results in aberrant nascent peptides attached to large ribosomal subunits after ribosome splitting. Proteasomal peptide degradation is canonically initiated by the Ribosome-associated Quality Control (RQC) complex, including K48-linked polyubiquitination by Ltn1 and Rqc1, and addition of non-templated ‘CAT tails’ by Rqc2 facilitates ubiquitination and promotes CAT tail-mediated degradation. Ubiquitinated peptides are released from tRNA by Vms1. Ubiquitination-independent processing of aberrant nascent peptides remains poorly understood. Here, we identify budding yeast Jlp2 as a factor in an RQC complex-independent mechanism that counteracts excessive CAT tailing and facilitates peptide release from the tRNA in the absence of Ltn1-mediated K48-linked ubiquitination. We characterize its ribosomal binding behavior and substrate preferences and identify residues in Jlp2 that are crucial for its function. We propose that Jlp2-mediated peptide release acts as a fail-safe for situations of RQC failure, or insufficiency, and for substrates without accessible ubiquitination-target lysines, to protect cells during ribosome stalling. Graphical
Open AccessJlp2 is an RQC complex-independent release factor acting on aberrant peptidyl-tRNA, protecting cells against translation elongation stress
Summary: Ribosome stalling results in aberrant nascent peptides attached to large ribosomal subunits after ribosome splitting. Proteasomal peptide degradation is canonically initiated by the Ribosome-associated Quality Control (RQC) complex, including K48-linked polyubiquitination by Ltn1 and Rqc1, and addition of non-templated ‘CAT tails’ by Rqc2 facilitates ubiquitination and promotes CAT tail-mediated degradation. Ubiquitinated peptides are released from tRNA by Vms1. Ubiquitination-independent processing of aberrant nascent peptides remains poorly understood. Here, we identify budding yeast Jlp2 as a factor in an RQC complex-independent mechanism that counteracts excessive CAT tailing and facilitates peptide release from the tRNA in the absence of Ltn1-mediated K48-linked ubiquitination. We characterize its ribosomal binding behavior and substrate preferences and identify residues in Jlp2 that are crucial for its function. We propose that Jlp2-mediated peptide release acts as a fail-safe for situations of RQC failure, or insufficiency, and for substrates without accessible ubiquitination-target lysines, to protect cells during ribosome stalling. Graphical
- Open Access
Yeast elongation factor homolog New1 protects a subset of mRNAs from degradation by no-go decay
New1 is a homologue of the essential yeast translation elongation factor eEF3. Lack of New1 has previously been shown to induce queueing of ribosomes upstream of the stop codon on mRNAs encoding specific C-terminal amino acids, primarily lysine and arginine. Here, we used UV crosslinking and analysis of cDNA, long-read nanopore sequencing and proteomics to address the open question of what consequences such queues have for the yeast cell. We show that these queues are ribosomal collisions, which are recognized by the collision sensor and E3 ubiquitin ligase Hel2, marking these collided ribosome complexes for mRNA degradation via canonical no-go decay. Decay is initiated by Cue2-mediated cleavage upstream of the stop codon. Ultimately, this leads to downregulation of encoded proteins, including highly abundant and important metabolic enzymes Pgk1 and Gpm1, as well as translation elongation factors eEF1-alpha and eEF1-beta. Collisions and resulting downstream effects are codon-, rather than amino acid dependent. E.g., for C-terminal lysine and arginine, only specific codons induce collisions upon lack of New1. Our study shows that New1 protects highly abundant and essential genes from degradation by no-go decay thatwould otherwise occur in the absence of translation inhibitors or other direct perturbations of translation.
Open AccessYeast elongation factor homolog New1 protects a subset of mRNAs from degradation by no-go decay
New1 is a homologue of the essential yeast translation elongation factor eEF3. Lack of New1 has previously been shown to induce queueing of ribosomes upstream of the stop codon on mRNAs encoding specific C-terminal amino acids, primarily lysine and arginine. Here, we used UV crosslinking and analysis of cDNA, long-read nanopore sequencing and proteomics to address the open question of what consequences such queues have for the yeast cell. We show that these queues are ribosomal collisions, which are recognized by the collision sensor and E3 ubiquitin ligase Hel2, marking these collided ribosome complexes for mRNA degradation via canonical no-go decay. Decay is initiated by Cue2-mediated cleavage upstream of the stop codon. Ultimately, this leads to downregulation of encoded proteins, including highly abundant and important metabolic enzymes Pgk1 and Gpm1, as well as translation elongation factors eEF1-alpha and eEF1-beta. Collisions and resulting downstream effects are codon-, rather than amino acid dependent. E.g., for C-terminal lysine and arginine, only specific codons induce collisions upon lack of New1. Our study shows that New1 protects highly abundant and essential genes from degradation by no-go decay thatwould otherwise occur in the absence of translation inhibitors or other direct perturbations of translation.
- 13 September 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (20)
Cover Feature: Molecular Highway Patrol for Ribosome Collisions (ChemBioChem 20/2023)
- 13 September 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (20)
Cover Feature: Molecular Highway Patrol for Ribosome Collisions (ChemBioChem 20/2023)
- Open Access
- 10 August 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (20) , e202300264
Molecular Highway Patrol for Ribosome Collisions
During translation, messenger RNAs (mRNAs) are decoded by ribosomes which can stall for various reasons. These include chemical damage, codon composition, starvation, or translation inhibition. Trailing ribosomes can collide with stalled ribosomes, potentially leading to dysfunctional or toxic proteins. Such aberrant proteins can form aggregates and favor diseases, especially neurodegeneration. To prevent this, both eukaryotes and bacteria have evolved different pathways to remove faulty nascent peptides, mRNAs and defective ribosomes from the collided complex. In eukaryotes, ubiquitin ligases play central roles in triggering downstream responses and several complexes have been characterized that split affected ribosomes and facilitate degradation of the various components. As collided ribosomes signal translation stress to affected cells, in eukaryotes additional stress response pathways are triggered when collisions are sensed. These pathways inhibit translation and modulate cell survival and immune responses. Here, we summarize the current state of knowledge about rescue and stress response pathways triggered by ribosome collisions.
- 10 August 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (20) , e202300264
Open AccessMolecular Highway Patrol for Ribosome Collisions
During translation, messenger RNAs (mRNAs) are decoded by ribosomes which can stall for various reasons. These include chemical damage, codon composition, starvation, or translation inhibition. Trailing ribosomes can collide with stalled ribosomes, potentially leading to dysfunctional or toxic proteins. Such aberrant proteins can form aggregates and favor diseases, especially neurodegeneration. To prevent this, both eukaryotes and bacteria have evolved different pathways to remove faulty nascent peptides, mRNAs and defective ribosomes from the collided complex. In eukaryotes, ubiquitin ligases play central roles in triggering downstream responses and several complexes have been characterized that split affected ribosomes and facilitate degradation of the various components. As collided ribosomes signal translation stress to affected cells, in eukaryotes additional stress response pathways are triggered when collisions are sensed. These pathways inhibit translation and modulate cell survival and immune responses. Here, we summarize the current state of knowledge about rescue and stress response pathways triggered by ribosome collisions.